Latest period
$10.97B
YoY change
+7.9%
5Y CAGR
+31.1%
Peak year (2025)
$11.48B
Latest annual
$11.48B
Total Equity history chart for Xylem (XYL) from 2009 to 2025
Latest: $11.48B
Total Equity growth chart for Xylem (XYL) from 2009 to 2025
Latest: +7.9%
Total Equity history table for Xylem (XYL) from 2009 to 2025
| 2025 | $11.48B | +7.9% | +$838.00M | ||
| 2024 | $10.64B | +4.7% | +$476.00M | ||
| 2023 | $10.17B | +191.0% | +$6.67B | ||
| 2022 | $3.49B | +8.6% | +$276.00M | ||
| 2021 | $3.22B | +8.4% | +$250.00M | ||
| 2020 | $2.97B | +0.4% | +$11.00M | ||
| 2019 | $2.96B | +6.8% | +$189.00M | ||
| 2018 | $2.77B | +10.6% | +$265.00M | ||
| 2017 | $2.50B | +14.3% | +$313.00M | ||
| 2016 | $2.19B | +5.1% | +$106.00M | ||
| 2015 | $2.08B | -2.0% | −$43.00M | ||
| 2014 | $2.13B | -5.1% | −$114.00M | ||
| 2013 | $2.24B | +8.1% | +$167.00M | ||
| 2012 | $2.07B | +13.5% | +$247.00M | ||
| 2011 | $1.83B | -32.8% | −$892.00M | ||
| 2010 | $2.72B | +61.2% | +$1.03B | ||
| 2009 | $1.69B | — | — |
- 2025$11.48B+7.9%
- 2024$10.64B+4.7%
- 2023$10.17B+191.0%
- 2022$3.49B+8.6%
- 2021$3.22B+8.4%
- 2020$2.97B+0.4%
- 2019$2.96B+6.8%
- 2018$2.77B+10.6%
- 2017$2.50B+14.3%
- 2016$2.19B+5.1%
- 2015$2.08B-2.0%
- 2014$2.13B-5.1%
- 2013$2.24B+8.1%
- 2012$2.07B+13.5%
- 2011$1.83B-32.8%
- 2010$2.72B+61.2%
- 2009$1.69B—
Total Equity values are taken from Xylem's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at Xylem (XYL)
According to Xylem's latest reported financial statements, the company's latest reported total equity is $10.97B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Xylem (XYL) total equity is $11.48B – grew 7.9% year-over-year.
Xylem total equity compound annual growth for the 2020–2025 (5 years) window is +31.1%, sustaining 10 straight years of year-over-year growth.
$11.48B stands as the all-time-high annual total equity, posted in 2025, against a low of $1.69B during 2009.
Xylem Total Equity by Year
Xylem Total Equity 2025: $11.48B
Xylem posted total equity of $11.48B in 2025, grew 7.9% from 2024. This figure represents the highest annual value in the available history.
Xylem Total Equity 2024: $10.64B
In 2024, Xylem reported total equity of $10.64B, edged up 4.7% from 2023.
Xylem Total Equity 2023: $10.17B
Xylem total equity in 2023 was $10.17B, surged 191.0% from 2022.
Xylem Total Equity 2022: $3.49B
2022's total equity for Xylem came in at $3.49B, grew 8.6% from 2021.
Xylem Total Equity 2021: $3.22B
Xylem total equity in 2021 was $3.22B.
See more financial history for Xylem (XYL).
Sector peers by Total Equity
Industrials peers of Xylem (XYL), ranked by their latest total equity
| $65.25B | |
| $25.95B | |
| $21.32B | |
| $19.43B | |
| $18.68B | |
| $18.47B | |
| $15.44B | |
| $5.45B |
- $65.25B
- $25.95B
- $21.32B
- $19.43B
- $18.68B
- $18.47B
- $5.45B
Frequently asked questions
Xylem (XYL) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation